Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 17 Neoplasms 9 Polycystic Ovary Syndrome 7 Multiple Myeloma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1

Interventions

Peripheral Blood Stem Cell Transplantation 22 Rituximab 18 Cyclophosphamide 15 fludarabine phosphate 14 Mycophenolic Acid 13 Cyclosporine 13 Tacrolimus 12 Filgrastim 11 Therapeutics 10 Whole-Body Irradiation 9 Etoposide 9 Radiotherapy 8 Methotrexate 8 Flow Cytometry 8 Psychiatric Rehabilitation 7 Methylprednisolone 7 Busulfan 7 Antilymphocyte Serum 7 Polymerase Chain Reaction 6 Cladribine 6 immunotoxin HA22 5 Lenalidomide 5 obinutuzumab 4 Vemurafenib 4 Melphalan 4 Granulocyte Colony-Stimulating Factor 4 merphos 3 ibrutinib 3 fludarabine 3 Vorinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed

113 enrolled 42 charts

Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡